sodium phosphate (NaH2PO4)

From Aaushi
Jump to navigation Jump to search

Indications

Contraindications

Dosage

Injection:

Adverse effects

* phosphate toxicity can result in hypocalcemic tetany[3] & chronic renal failure[4][6][7] risk of acute phosphate nephropathy is low[5]

More general terms

More specific terms

Additional terms

Component of

References

  1. Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
  2. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  3. 3.0 3.1 Medications Can Cause Seizures Prescriber's Letter 10(3):16 2003 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=190320&pb=PRL (subscription needed) http://www.prescribersletter.com
  4. 4.0 4.1 Markowitz GS, Stokes MB, Radhakrishnan J, D'Agati VD. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol. 2005 Nov;16(11):3389-96. Epub 2005 Sep 28. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16192415
  5. 5.0 5.1 Russman S et al, Risk of impaired renal function after colonoscopy: A cohort study of patients receiving either oral sodium phosphoate or polyethylene glycol. Am J Gastroenterol 2007, 102:2655 PMID: https://www.ncbi.nlm.nih.gov/pubmed/17970832
  6. 6.0 6.1 6.2 Prescriber's Letter 15(5): 2008 Kidney Damage from Sodium Phosphate Bowel Preps Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=240505&pb=PRL (subscription needed) http://www.prescribersletter.com
  7. 7.0 7.1 FDA MedWatch http://www.fda.gov/medwatch/safety/2008/safety08.htm#OSP
  8. 8.0 8.1 Prescriber's Letter 16(1): 2009 Oral Sodium Phosphate Products for Bowel Cleansing: More Safety Concerns Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=250114&pb=PRL (subscription needed) http://www.prescribersletter.com
  9. 9.0 9.1 9.2 Deprecated Reference
  10. 10.0 10.1 FDA MedWatch. Jan 8, 2014 Sodium Phosphate Over-the-Counter Products: Drug Safety Communication - Possible Harm From Exceeding Recommended Dose. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm380833.htm

Database